Related Experiment Video
Updated: Feb 9, 2026

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
Published on: February 28, 2021
Complex Medical Decision-Making for a Trans-Feminine Youth with a BRCA1 Mutation
Carolyn S Wolf-Gould1, Moira R Riley2, Jeremi M Carswell3
11 The Gender Wellness Center/Susquehanna Family Practice, AO Fox Hospital, Bassett Healthcare Network , Oneonta, New York.
Abstract:
The risks of being a cisgender BRCA1/BRCA2 mutation carrier (BRCA1+/BRCA2+) are well documented, and recommendations to mitigate cancer risk in BRCA+ cisgender women are clear. However, there is a lack of guidance for BRCA+ transgender women. In this article, we discuss the case of a trans-feminine youth who presented at a gender clinic for medications for pubertal suppression and was identified as a BRCA1 mutation carrier. We explore principles of bioethics to consider when the potential risks of treatment are unclear. We discuss the unknown risks for a trans-feminine youth with a BRCA1 mutation and the potential benefits and risks of treatment options.
More Related Videos
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Decision Making
Automatic decision-making is fast, intuitive, and relies on gut feelings...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

